Clinical Trials Directory

Trials / Unknown

UnknownNCT02801708

Enhanced Detection of Underlying, Covert ATrial Fibrillation Using 7-day Holter Electrocardiogram in Patients With Embolic Stroke of Undetermined Source

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
National Cerebral and Cardiovascular Center, Japan · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the diagnostic yield of continuous 7-day Holter ECG for detecting covert paroxysmal atrial fibrillation in patients with recent embolic stroke or transient ischemic attack (TIA) of undetermined cause after completion of a standard clinical work up including an initial 24-hour Holter monitoring.

Detailed description

Covert atrial fibrillation (AF) is a relevant potential cause of a recently proposed clinical construct, "Embolic Stroke of Undetermined Source (ESUS)". However, routine post-stroke work up including 24-hour Holter monitoring may fail to detect paroxysmal AF. A recent systematic review has shown an increased AF detection rate with longer monitoring durations. The aim of this study is to evaluate the effectiveness of a novel ambulatory 7-day Holter ECG (EV-201, Parama-Tech inc.) for detecting AF in patients with recent ESUS after completion of a standard clinical examination.

Conditions

Timeline

Start date
2014-08-01
Primary completion
2018-03-01
Completion
2019-03-01
First posted
2016-06-16
Last updated
2016-12-02

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02801708. Inclusion in this directory is not an endorsement.

Enhanced Detection of Underlying, Covert ATrial Fibrillation Using 7-day Holter Electrocardiogram in Patients With Embol (NCT02801708) · Clinical Trials Directory